Tsea I, Olsen T, Polychronopoulos P, Tummler C, Sykes D, Baryawno N
Cancers (Basel). 2025; 16(24.
PMID: 39766063
PMC: 11674817.
DOI: 10.3390/cancers16244162.
Jin Y, Lu T, Liu B, Wang Y
Acta Neurochir (Wien). 2024; 166(1):413.
PMID: 39412555
DOI: 10.1007/s00701-024-06309-2.
Ashurov J, Musa G, Kumirova E, Margaryan S, Livshitz M, Ozerov S
Cureus. 2024; 16(8):e68239.
PMID: 39347241
PMC: 11439456.
DOI: 10.7759/cureus.68239.
Ceccarelli M, Rossi S, Bonaventura F, Massari R, DElia A, Soluri A
Brain Pathol. 2024; 35(1):e13283.
PMID: 38946128
PMC: 11669415.
DOI: 10.1111/bpa.13283.
Holmberg K, Borgenvik A, Zhao M, Giraud G, Swartling F
Cancers (Basel). 2024; 16(9).
PMID: 38730706
PMC: 11083189.
DOI: 10.3390/cancers16091752.
The Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas.
Ampudia-Mesias E, Cameron C, Yoo E, Kelly M, Anderson S, Manning R
Int J Mol Sci. 2024; 25(8).
PMID: 38674001
PMC: 11050316.
DOI: 10.3390/ijms25084416.
KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis.
Sanghrajka R, Koche R, Medrano H, El Nagar S, Stephen D, Lao Z
iScience. 2023; 26(10):107831.
PMID: 37822508
PMC: 10562805.
DOI: 10.1016/j.isci.2023.107831.
Inhibition of metastatic brain cancer in Sonic Hedgehog medulloblastoma using caged nitric oxide albumin nanoparticles.
Soltys B, Grausam K, Messerli S, Hsia C, Zhao H
Front Oncol. 2023; 13:1129533.
PMID: 37213306
PMC: 10197928.
DOI: 10.3389/fonc.2023.1129533.
Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner.
Jackson H, Mitoko C, Linke F, Macarthur D, Kerr I, Coyle B
Cancers (Basel). 2023; 15(9).
PMID: 37174066
PMC: 10177484.
DOI: 10.3390/cancers15092601.
Leptomeningeal dissemination in pediatric brain tumors.
Cocito C, Martin B, Giantini-Larsen A, Valcarce-Aspegren M, Souweidane M, Szalontay L
Neoplasia. 2023; 39:100898.
PMID: 37011459
PMC: 10124141.
DOI: 10.1016/j.neo.2023.100898.
The phosphorylation of PHF5A by TrkA-ERK1/2-ABL1 cascade regulates centrosome separation.
Song C, Zhang Y, Li Y, Bie J, Wang Z, Yang X
Cell Death Dis. 2023; 14(2):98.
PMID: 36759599
PMC: 9911754.
DOI: 10.1038/s41419-023-05561-1.
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.
Okonechnikov K, Federico A, Schrimpf D, Sievers P, Sahm F, Koster J
Acta Neuropathol Commun. 2023; 11(1):7.
PMID: 36635768
PMC: 9837941.
DOI: 10.1186/s40478-023-01504-1.
The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitro.
Schoen L, Craveiro R, Pietsch T, Moritz T, Troeger A, Jordans S
J Cell Mol Med. 2022; 26(23):5832-5845.
PMID: 36377725
PMC: 9716228.
DOI: 10.1111/jcmm.17604.
Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma.
Marabitti V, Giansanti M, De Mitri F, Gatto F, Mastronuzzi A, Nazio F
Front Cell Dev Biol. 2022; 10:1007641.
PMID: 36340043
PMC: 9627342.
DOI: 10.3389/fcell.2022.1007641.
Role of Circular RNA in Brain Tumor Development.
Ahmed S, Castresana J, Shahi M
Cells. 2022; 11(14).
PMID: 35883576
PMC: 9315629.
DOI: 10.3390/cells11142130.
Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma.
Zhang J, Yuan X, Wang Y, Liu J, Li Z, Li S
Front Oncol. 2022; 12:893132.
PMID: 35860588
PMC: 9289152.
DOI: 10.3389/fonc.2022.893132.
ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma.
Fratini L, Dalmolin M, Sinigaglia M, da Silveira Perla A, de Farias C, Brunetto A
Neuromolecular Med. 2022; 25(1):64-74.
PMID: 35716340
DOI: 10.1007/s12017-022-08716-z.
Identification of PBK as a hub gene and potential therapeutic target for medulloblastoma.
Deng Y, Wen H, Yang H, Zhu Z, Huang Q, Bi Y
Oncol Rep. 2022; 48(1).
PMID: 35593307
PMC: 9164263.
DOI: 10.3892/or.2022.8336.
3D-on-2D: A Physiologically Relevant and Gel-Free In Vitro Coculture Method to Assay Antimetastatic Agents.
Dey A, Eisenberg S, Birnbaum R, Sharp D
Methods Mol Biol. 2022; 2423:103-107.
PMID: 34978692
DOI: 10.1007/978-1-0716-1952-0_10.
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives.
Voskamp M, Li S, van Daalen K, Crnko S, Ten Broeke T, Bovenschen N
Cancers (Basel). 2021; 13(21).
PMID: 34771550
PMC: 8582409.
DOI: 10.3390/cancers13215387.